Infectious Diseases

The US Food and Drug Administration (FDA) discussed its latest drug and testing efforts to respond to coronavirus 2019 disease.

With the authorization of 2 vaccines in late 2020 it seemed like a corner had been turned with the pandemic. A recent poll offers insight into how the public feels like the pandemic is going and when the disruptions caused by it might end.

As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?

A report offers much needed information on whether very young children are at greater risk of having a severe disease course of coronavirus 2019 (COVID-19).

Vaccine hesitancy is nothing new in pediatrics. However, the increased hesitancy for the COVID-19 vaccine could prove problematic.

The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of monoclonal antibodies bamlanivimab and etesevimab to treat mild coronavirus disease 2019 (COVID-19) in both pediatric and adult patients.

Improving influenza vaccination coverage is important for all children, but some are at greater risk for poorer outcomes. A review examines whether interventions can improve vaccine coverage.

Survey suggests many will continue pandemic precautions after the crisis ends.

The loneliness and isolation of the pandemic has wreaked havoc on the mental health of many. A report examines whether this translated into more suicidal ideation and behavior.

Traditional flu season has collided with the pandemic. Here’s what you need to know.

A report examines if the influenza and pneumococcal vaccine has a protective effect against COVID-19.

The American Academy of Pediatrics (AAP) has issued initial guidance for COVID-19 vaccination in pediatrics.

It is more important than ever for health care professionals to remember that overprescribing these drugs can have life-threatening consequences.

Does using methylprednisolone along with intravenous immunoglobulins improve fever outcomes for multisystem inflammatory syndrome in children (MIS-C) cases? A French investigation offers some answers.

Cytomegalovirus (CMV) is linked to hearing loss in affected children. An investigation looks into whether the viral load impacts this risk.

A pediatric infectious disease specialist discusses where we are at with children's vaccines for COVID-19.

Moderna has announced further research into whether a booster shot could provide additional protection with new COVID-19 variants.

An investigation looks at the neurological manifestations of COVID-19.

With the good news of the 2 successful vaccines and a much greater understanding of COVID-19, it is time to consider what lies ahead for 2021.

The COVID-19 pandemic has had a severe negative toll on the mental health of many children. Here are some tips to help children achieve better psychological well-being.

The Biden transition team has named more members of the COVID-19 response team, including pediatrician and lawyer Dr. Kessler.

What we knew about COVID-19 when the pandemic began, what we know now.

The American Academy of Pediatrics (AAP) has updated their safety guidance for in-person schooling during the pandemic.

The Infectious Diseases Society of America (ISDA) has updated recommendations for COVID-19 diagnostic testing.

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.

Believe it or not, there was a sunny side to 2020.

A look at how we learned to protect ourselves and our patients from COVID-19 over the past year.

Several reports coming out of the United Kingdom are suggesting that the newest variant of COVID-19 might be more infectious for children.

The National Institutes of Health award 8 research grants to develop ways to identify children at high risk for multi system inflammatory syndrome I children (MIS-C).

Social distancing measures may have helped slow the spread of COVID-19 in the early days of the pandemic, but an investigation indicates an unintended and potentially problematic consequence: a decline in vaccination.